DELFI Diagnostics to Present Cancer Detection and Monitoring Updates at AACR
April 28, 2025
Fragmentomics pioneer showcases DELFI-TF treatment monitoring solution alongside early detection capabilities at a premier oncology research event DELFI Diagnostics, Inc., developer of innovative blood-based tests